Stock Research for GTXI

GTXI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GTXI Stock Chart & Research Data

The GTXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GTXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GTXI Due diligence Resources & Stock Charts

The GTXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GTXI Detailed Price Forecast - CNN Money CNN View GTXI Detailed Summary - Google Finance
Yahoo View GTXI Detailed Summary - Yahoo! Finance Zacks View GTXI Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View GTXI Trends & Analysis - Trade-Ideas Barrons View GTXI Major Holders - Barrons
NASDAQ View GTXI Call Transcripts - NASDAQ Seeking View GTXI Breaking News & Analysis - Seeking Alpha
Spotlight View GTXI Annual Report - CompanySpotlight.com OTC Report View GTXI OTC Short Report - OTCShortReport.com
TradeKing View GTXI Fundamentals - TradeKing Charts View GTXI SEC Filings - Bar Chart
WSJ View Historical Prices for GTXI - The WSJ Morningstar View Performance/Total Return for GTXI - Morningstar
MarketWatch View the Analyst Estimates for GTXI - MarketWatch CNBC View the Earnings History for GTXI - CNBC
StockMarketWatch View the GTXI Earnings - StockMarketWatch MacroAxis View GTXI Buy or Sell Recommendations - MacroAxis
Bullish View the GTXI Bullish Patterns - American Bulls Short Pains View GTXI Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View GTXI Stock Mentions - StockTwits PennyStocks View GTXI Stock Mentions - PennyStockTweets
Twitter View GTXI Stock Mentions - Twitter Invest Hub View GTXI Investment Forum News - Investor Hub
Yahoo View GTXI Stock Mentions - Yahoo! Message Board Seeking Alpha View GTXI Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for GTXI - SECform4.com Insider Cow View Insider Transactions for GTXI - Insider Cow
CNBC View GTXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GTXI - OTC Markets
Yahoo View Insider Transactions for GTXI - Yahoo! Finance NASDAQ View Institutional Holdings for GTXI - NASDAQ


Stock Charts

FinViz View GTXI Stock Insight & Charts - FinViz.com StockCharts View GTXI Investment Charts - StockCharts.com
BarChart View GTXI Stock Overview & Charts - BarChart Trading View View GTXI User Generated Charts - Trading View


Latest Financial News for GTXI

GTx to Present Phase 2 Enobosarm Clinical Trial Results in Stress Urinary Incontinence at a Podium Presentation at 2018 AUA Annual Meeting
Posted on Monday April 16, 2018

GTx, Inc. today announced an upcoming podium presentation highlighting the clinical results from the Company’s open-label, Phase 2 proof-of-concept clinical trial evaluating enobosarm 3 mg in postmenopausal women with stress urinary incontinence .


Research Report Identifies Third Point Reinsurance, GTx, pdvWireless, ACM Research, Reading International, and Canadian National Railway with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Friday April 13, 2018

NEW YORK, April 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...


Blog Exposure - GTx Completed Patient Enrollment Several Months Ahead in the Phase-2 Clinical Trial of Enobosarm in SUI
Posted on Wednesday April 11, 2018

Stock Monitor: TapImmune Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 11, 2018 / Active-Investors.com has just released a free research report on GTx, Inc. (NASDAQ: GTXI ). If you want access ...


GTx Announces Early Completion of Patient Enrollment in the ASTRID Trial, a Phase 2 Clinical Trial of Enobosarm in Stress Urinary Incontinence
Posted on Monday April 09, 2018

GTx, Inc.  today announced that it has completed patient enrollment several months ahead of schedule in its placebo-controlled, Phase 2 clinical trial of enobosarm in postmenopausal women with stress urinary incontinence .


Enter a stock symbol to view the stock details.